This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Ionctura Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Lahn: Inventor in PI3K-δ Inhibitor Research.
Introduction
Michael Lahn is an inventor based in Geneva, Switzerland. His patent work concerns a PI3K-δ inhibitor intended for treatment regimens addressing diseases in which the PI3Kδ pathway is pathologically implicated.
Latest Patents
Lahn is associated with one patent, titled “PI3K-δ inhibitor for use in treatment regimens.” It describes a compound, or a pharmaceutically acceptable salt of the compound, for treating conditions such as cancer and inflammatory or autoimmune diseases. The patent specifies a dose and reports a favorable safety profile in humans, particularly regarding hepatotoxicity, diarrhea or colitis, respiratory infections, and hematologic toxicities. The supplied information lists 1 patent.
Career Highlights
Lahn has worked with Ionctura SA and Ionctura BV. His listed patent reflects work on the therapeutic use and safety profile of a PI3K-δ inhibitor.
Collaborations
His listed coworkers include Catherine Pickering and Zoë Johnson.
Conclusion
Michael Lahn’s patent activity, as described in the supplied information, centers on a PI3K-δ inhibitor for potential use in cancer and inflammatory or autoimmune disease treatment regimens.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile